Skip to main content
Premium Trial:

Request an Annual Quote

Evonik, Genedata Renew License Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genedata said today that life sciences and chemicals company Evonik has renewed a license agreement for Genedata's research data management and molecular profiling system.

Under the license agreement, Evonik will use the Genedata Phylosopher and Expressionist systems for a range of applications, including production strain optimization for feed; food and pharma amino acids and derivatives; process monitoring for fermentation-based production; and novel developments for care specialties.

The Phylosopher software enables the company to "centrally manage all data related to our proprietary production strains and processes," Stephen Hans, head of Evonik's Functional Cell Analysis Group, R&D Bioproducts, said in a statement.

Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.